Skip to main content

Omnipod 5 becomes the latest hybrid closed loop system available in the UK

Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.
21 June 2023

A woman standing in a park using the Omnipod 5 system for type 1 diabetes

Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.

What is Omnipod 5?

Omnipod 5 is the first tubeless hybrid closed loop system. The pod-style insulin pump integrates with the Dexcom G6 continuous glucose monitor (CGM) via the Omnipod 5 Controller.

What features does this HCL system have?

Omnipod 5 has an integrated algorithm called the ‘SmartBolus Calculator’, which automatically responds to your CGM glucose value and trend, so you don’t have to. It also comes with an activity feature which, when enabled, reduces insulin delivery, and raises the glucose target in situations where you need less insulin, for example when exercising.

A graphic of the Omnipod 5

The insulin pump

Similar to the Omnipod DASH, the insulin pump in the Omnipod 5 system is a new version of Insulet’s wireless pod-style pumps. The new pump in the Omnipod 5 system is waterproof and enhanced with SmartAdjust™ technology. The device automatically increases, decreases, or pauses basal insulin delivery every five minutes based on your personal target glucose levels.

The continuous glucose monitor

The Omnipod 5 HCL system only works with the Dexcom G6 sensor. This CGM has shareability and alert features. Dexcom D6 is available on the NHS through your diabetes clinic or can be purchased separately from the Omnipod 5.

Will Omnipod 5 be available on the NHS?

The National Institute for Health and Care Excellence (NICE, the body which advises the NHS on treatments and technologies), is currently reviewing its recommendations for HCL technology to be made available on the NHS. We are expecting NICE’s final decision in September.

Omnipod 5 is now available on the NHS frameworks and Insulet is working with NHS Trusts to make Omnipod 5 available locally as rapidly as possible. Please check availability with your local diabetes team at your next planned consultation. Insulet also has a team dedicated to support you with this and product related queries. you can contact Insulet by calling 0800 011 6132 and pressing option 4 or by emailing omnipodinfogb@insulet.com.

Who can use Omnipod 5?

The Omnipod 5 HCL system is approved for people with type 1 diabetes who are aged 2 years and older.

Our CEO, Karen Addington, said:

“With NICE set to recommend hybrid closed loop in England and Wales later this year, we are delighted that more hybrid closed loop systems such as the Omnipod 5 are becoming available to help people manage their type 1 diabetes. Diabetes management is very personal, so access to a range of technology options is crucial. A wider choice of hybrid closed loop systems offers people with type 1 evidence-based technology they can trust to support them to manage their condition with confidence.”

How does Omnipod 5 work?

Related news

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Treatment research
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Type 1 technology
21 August 2023

NICE’s latest consultation on hybrid closed loop

As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.

Read more
A hybrid closed loop technology sensor
Type 1 technology
27 April 2023

Abbott, Ypsomed and CamDiab team up to offer hybrid closed loop with more affordable sensor technology

Abbott has announced that its FreeStyle Libre® 3 sensor is now authorised to work with Ypsomed’s mylife™ YpsoPump and CamDiab’s CamAPS FX mobile app.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Type 1 technology
13 January 2023

Hybrid closed loop to be recommended for over 100,000 people with type 1 diabetes

Draft guidance has been published which recommends that the NHS fund hybrid closed loop (HCL) systems, following years of dedicated research and campaigning by JDRF.